Macrophages represent heterogeneous cell population with important roles in defence mechanisms and in homoeostasis. Tissue macrophages from diverse anatomical locations adopt distinct activation states. M1 and M2 macrophages are two polarized forms of mononuclear phagocyte in vitro differentiation with distinct phenotypic patterns and functional properties, but in vivo, there is a wide range of different macrophage phenotypes in between depending on the microenvironment and natural signals they receive. In human infections, pathogens use different strategies to combat macrophages and these strategies include shaping the macrophage polarization towards one or another phenotype. Macrophages infiltrating the tumours can affect the patient's prognosis. M2 macrophages have been shown to promote tumour growth, while M1 macrophages provide both tumour-promoting and anti-tumour properties. In autoimmune diseases, both prolonged M1 activation, as well as altered M2 function can contribute to their onset and activity. In human atherosclerotic lesions, macrophages expressing both M1 and M2 profiles have been detected as one of the potential factors affecting occurrence of cardiovascular diseases. In allergic inflammation, T2 cytokines drive macrophage polarization towards M2 profiles, which promote airway inflammation and remodelling. M1 macrophages in transplantations seem to contribute to acute rejection, while M2 macrophages promote the fibrosis of the graft. The view of pro-inflammatory M1 macrophages and M2 macrophages suppressing inflammation seems to be an oversimplification because these cells exploit very high level of plasticity and represent a large scale of different immunophenotypes with overlapping properties. In this respect, it would be more precise to describe macrophages as M1-like and M2-like.

3rd Department of Surgery 1st Faculty of Medicine Charles University and University Hospital Motol 5 Uvalu 84 15006 Prague Czech Republic

Chemokine Research Group Institute of Infection Immunity and Inflammation College of Medical Veterinary and Life Sciences University of Glasgow Glasgow G12 8TT U K

Department of Clinical and Transplant Immunology Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Immunology 2nd Faculty of Medicine Charles University and University Hospital Motol 5 Uvalu 84 15006 Prague Czech Republic

Institute of Immunology and Microbiology 1st Faculty of Medicine Charles University Prague Czech Republic

See more in PubMed

Nobs S.P. and Kopf M. (2021) Tissue-resident macrophages: guardians of organ homeostasis. Trends Immunol. 42, 495–507 10.1016/j.it.2021.04.007 PubMed DOI

Ginhoux F. and Guilliams M. (2016) Tissue-resident macrophage ontogeny and homeostasis. Immunity 44, 439–449 10.1016/j.immuni.2016.02.024 PubMed DOI

Sieweke M.H. and Allen J.E. (2013) Beyond stem cells: self-renewal of differentiated macrophages. Science 342, 1242974 10.1126/science.1242974 PubMed DOI

Gautier E.L., Shay T., Miller J., Greter M., Jakubzick C., Ivanov S.et al. . (2012) Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13, 1118–1128 10.1038/ni.2419 PubMed DOI PMC

Bene K., Halasz L. and Nagy L. (2021) Transcriptional repression shapes the identity and function of tissue macrophages. FEBS Open Bio. 11, 3218–3229 10.1002/2211-5463.13269 PubMed DOI PMC

Vlahos R. and Bozinovski S. (2014) Role of alveolar macrophages in chronic obstructive pulmonary disease. Front. Immunol. 5, 435 10.3389/fimmu.2014.00435 PubMed DOI PMC

Bain C.C. and MacDonald A.S. (2022) The impact of the lung environment on macrophage development, activation and function: diversity in the face of adversity. Mucosal Immunol. 15, 223–234 10.1038/s41385-021-00480-w PubMed DOI PMC

Zimmermann H., Trautwein C. and Tacke F. (2012) Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front. Physiol. 3, 56 10.3389/fphys.2012.00056 PubMed DOI PMC

Wen Y., Lambrecht J., Ju C. and Tacke F. (2021) Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cell. Mol. Immunol. 18, 45–56 10.1038/s41423-020-00558-8 PubMed DOI PMC

Arandjelovic S. and Ravichandran K.S. (2015) Phagocytosis of apoptotic cells in homeostasis. Nat. Immunol. 16, 907–917 10.1038/ni.3253 PubMed DOI PMC

Liu F., Dai S., Feng D., Qin Z., Peng X., Sakamuri S.S.V.P.et al. . (2020) Distinct fate, dynamics and niches of renal macrophages of bone marrow or embryonic origins. Nat. Commun. 11, 2280 10.1038/s41467-020-16158-z PubMed DOI PMC

Borges da Silva H., Fonseca R., Pereira R.M., Cassado A.d.A., Álvarez J.M. and D'Império Lima M.R. (2015) Splenic macrophage subsets and their function during blood-borne infections. Front. Immunol. 6, 10.3389/fimmu.2015.00480 PubMed DOI PMC

A-Gonzalez N. and Castrillo A. (2018) Origin and specialization of splenic macrophages. Cell. Immunol. 330, 151–158 10.1016/j.cellimm.2018.05.005 PubMed DOI

Brioschi S., Zhou Y. and Colonna M. (2020) Brain parenchymal and extraparenchymal macrophages in development, homeostasis, and disease. J. Immunol. 204, 294–305 10.4049/jimmunol.1900821 PubMed DOI PMC

Li Q. and Barres B.A. (2018) Microglia and macrophages in brain homeostasis and disease. Nat. Rev. Immunol. 18, 225–242 10.1038/nri.2017.125 PubMed DOI

Sinder B.P., Pettit A.R. and McCauley L.K. (2015) Macrophages: their emerging roles in bone. J. Bone Miner. Res. 30, 2140–2149 10.1002/jbmr.2735 PubMed DOI PMC

Boyce B.F., Yao Z. and Xing L. (2009) Osteoclasts have multiple roles in bone in addition to bone resorption. Crit. Rev. Eukaryot. Gene Expr. 19, 171–180 10.1615/CritRevEukarGeneExpr.v19.i3.10 PubMed DOI PMC

Iwanaga T., Shikichi M., Kitamura H., Yanase H. and Nozawa-Inoue K. (2000) Morphology and functional roles of synoviocytes in the joint. Arch. Histol. Cytol. 63, 17–31 10.1679/aohc.63.17 PubMed DOI

Kennedy A., Fearon U., Veale D.J. and Godson C. (2011) Macrophages in synovial inflammation. Front. Immunol. 2, 52 10.3389/fimmu.2011.00052 PubMed DOI PMC

Epelman S., Lavine K.J. and Randolph G.J. (2014) Origin and functions of tissue macrophages. Immunity 41, 21–35 10.1016/j.immuni.2014.06.013 PubMed DOI PMC

Lee C.Z.W. and Ginhoux F. (2022) Biology of resident tissue macrophages. Development 149, dev200270 10.1242/dev.200270 PubMed DOI

West H.C. and Bennett C.L. (2017) Redefining the role of langerhans cells as immune regulators within the skin. Front. Immunol. 8, 1941 10.3389/fimmu.2017.01941 PubMed DOI PMC

Doebel T., Voisin B. and Nagao K. (2017) Langerhans cells - the macrophage in dendritic cell clothing. Trends Immunol. 38, 817–828 10.1016/j.it.2017.06.008 PubMed DOI

Lavin Y., Winter D., Blecher-Gonen R., David E., Keren-Shaul H., Merad M.et al. . (2014) Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159, 1312–1326 10.1016/j.cell.2014.11.018 PubMed DOI PMC

Mills C.D., Kincaid K., Alt J.M., Heilman M.J. and Hill A.M. (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166–6173 10.4049/jimmunol.164.12.6166 PubMed DOI

Gordon S. and Martinez F.O. (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32, 593–604 10.1016/j.immuni.2010.05.007 PubMed DOI

Xue J., Schmidt S.V., Sander J., Draffehn A., Krebs W., Quester I.et al. . (2014) Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40, 274–288 10.1016/j.immuni.2014.01.006 PubMed DOI PMC

Murray P.J., Allen J.E., Biswas S.K., Fisher E.A., Gilroy D.W., Goerdt S.et al. . (2014) Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14–20 10.1016/j.immuni.2014.06.008 PubMed DOI PMC

van Furth R. and Cohn Z.A. (1968) The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128, 415–435 10.1084/jem.128.3.415 PubMed DOI PMC

Hoeffel G. and Ginhoux F. (2018) Fetal monocytes and the origins of tissue-resident macrophages. Cell. Immunol. 330, 5–15 10.1016/j.cellimm.2018.01.001 PubMed DOI

Alliot F., Godin I. and Pessac B. (1999) Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res. Dev. Brain Res. 117, 145–152 10.1016/S0165-3806(99)00113-3 PubMed DOI

Ziegler-Heitbrock H.W., Strobel M., Kieper D., Fingerle G., Schlunck T., Petersmann I.et al. . (1992) Differential expression of cytokines in human blood monocyte subpopulations. Blood 79, 503–511 10.1182/blood.V79.2.503.503 PubMed DOI

Ziegler-Heitbrock L. (2014) Monocyte subsets in man and other species. Cell. Immunol. 289, 135–139 10.1016/j.cellimm.2014.03.019 PubMed DOI

Evren E., Ringqvist E., Tripathi K.P., Sleiers N., Rives I.C., Alisjahbana A.et al. . (2021) Distinct developmental pathways from blood monocytes generate human lung macrophage diversity. Immunity 54, 259e257–275e257 10.1016/j.immuni.2020.12.003 PubMed DOI

Olingy C.E., San Emeterio C.L., Ogle M.E., Krieger J.R., Bruce A.C., Pfau D.D.et al. . (2017) Non-classical monocytes are biased progenitors of wound healing macrophages during soft tissue injury. Sci. Rep. 7, 447 10.1038/s41598-017-00477-1 PubMed DOI PMC

Foey A.D., Feldmann M. and Brennan F.M. (2000) Route of monocyte differentiation determines their cytokine production profile: CD40 ligation induces interleukin 10 expression. Cytokine 12, 1496–1505 10.1006/cyto.2000.0750 PubMed DOI

Zizzo G. and Cohen P.L. (2013) IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids. J. Immunol. 190, 5237–5246 10.4049/jimmunol.1203017 PubMed DOI PMC

Boyette L.B., Macedo C., Hadi K., Elinoff B.D., Walters J.T., Ramaswami B.et al. . (2017) Phenotype, function, and differentiation potential of human monocyte subsets. PLoS ONE 12, e0176460 10.1371/journal.pone.0176460 PubMed DOI PMC

Konermann A., Stabenow D., Knolle P.A., Held S.A., Deschner J. and Jager A. (2012) Regulatory role of periodontal ligament fibroblasts for innate immune cell function and differentiation. Innate Immun. 18, 745–752 10.1177/1753425912440598 PubMed DOI

Krause S.W., Zaiss M., Kreutz M. and Andreesen R. (2001) Activation of lymphocytes inhibits human monocyte to macrophage differentiation. Immunobiology 203, 709–724 10.1016/S0171-2985(01)80001-2 PubMed DOI

Striz I., Slavcev A., Kalanin J., Jaresova M. and Rennard S.I. (2001) Cell-cell contacts with epithelial cells modulate the phenotype of human macrophages. Inflammation 25, 241–246 10.1023/A:1010975804179 PubMed DOI

Abdelaziz M.H., Abdelwahab S.F., Wan J., Cai W., Huixuan W., Jianjun C.et al. . (2020) Alternatively activated macrophages; a double-edged sword in allergic asthma. J. Transl. Med. 18, 10.1186/s12967-020-02251-w PubMed DOI PMC

Beyer M., Mallmann M.R., Xue J., Staratschek-Jox A., Vorholt D., Krebs W.et al. . (2012) High-resolution transcriptome of human macrophages. PLoS ONE 7, 45466 10.1371/journal.pone.0045466 PubMed DOI PMC

Essandoh K., Li Y., Huo J. and Fan G. (2016) MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock 46, 122–131 10.1097/SHK.0000000000000604 PubMed DOI PMC

Jablonski K.A., Amici S.A., Webb L.M., Ruiz-Rosado J.d.D., Popovich P.G., Partida-Sanchez S.et al. . (2015) Novel markers to delineate murine M1 and M2 macrophages. PLoS ONE 10, e0145342 10.1371/journal.pone.0145342 PubMed DOI PMC

Jaguin M., Houlbert N., Fardel O. and Lecureur V. (2013) Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell. Immunol. 281, 51–61 10.1016/j.cellimm.2013.01.010 PubMed DOI

Krausgruber T., Blazek K., Smallie T., Alzabin S., Lockstone H., Sahgal N.et al. . (2011) IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12, 231–238 10.1038/ni.1990 PubMed DOI

Li H., Jiang T., Li M., Zheng X. and Zhao G. (2018) Transcriptional regulation of macrophages polarization by MicroRNAs. Front. Immunol. 9, 1664–3224 10.3389/fimmu.2018.01175 PubMed DOI PMC

Mosser D.M. and Edwards J.P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immuno. 8, 958–969 10.1038/nri2448 PubMed DOI PMC

Ross E.A., Devitt A. and Johnson J.R. (2021) Macrophages: the good, the bad, and the gluttony. Front. Immunol. 12, 708186 10.3389/fimmu.2021.708186 PubMed DOI PMC

Shapouri-Moghaddam A., Mohammadian S., Vazini H.et al. . (2018) Macrophage plasticity, polarization, and function in health and disease. J. Cell. Physiol. 233, 6425–6440 10.1002/jcp.26429 PubMed DOI

Tarique A., Logan J., Thomas E., Holt P., Sly P. and Fantino E. (2015) Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. Am. J. Respir. Cell Mol. Biol. 53, 676–688 10.1165/rcmb.2015-0012OC PubMed DOI

Wang L.X., Zang S.-X., Wu H.J., Rong X.L. and Guo J. (2019) M2b macrophage polarization and its roles in diseases. J. Leukoc. Biol. 106, 345–358 10.1002/JLB.3RU1018-378RR PubMed DOI PMC

Koning N., van Eijk M., Pouwels W., Brouwer M.S., Voehringer D., Huitinga I.et al. . (2010) Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation. J. Innate Immun. 2, 195–200 10.1159/000252803 PubMed DOI

Murray P.J., Allen J.E., Biswas S.K., Fisher E.A., Gilroy D.W., Goerdt S.et al. . (2014) Macrophage activation and polarization: Nomenclature and experimental guidelines. Immunity 41, 14–20 10.1016/j.immuni.2014.06.008 PubMed DOI PMC

Yu T., Gan S., Zhu Q.et al. . (2019) Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24. Nat. Commun. 10, 4353 10.1038/s41467-019-12384-2 PubMed DOI PMC

Lurier E.B., Dalton D., Dampier W., Raman P., Nassiri S., Ferraro N.M.et al. . (2017) Transcriptome analysis of IL-10-stimulated (M2c) macrophages by next-generation sequencing. Immunobiology 7, 847–856 10.1016/j.imbio.2017.02.006 PubMed DOI PMC

Ferrante C.J., Pinhal-Enfield G., Elson G., Cronstein B.N., Hasko G., Outram S.et al. . (2013) The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Rα) signaling. Inflammation 36, 921–931 10.1007/s10753-013-9621-3 PubMed DOI PMC

Purcu D.U., Korkmaz A., Gunalp S., Helvaci D.G., Erdal Y., Dogan Y.et al. . (2022) Effect of stimulation time on the expression of human macrophage polarization markers. PLoS ONE 17, e0265196 10.1371/journal.pone.0265196 PubMed DOI PMC

Awad F., Assrawi E., Jumeau C., Georgin-Lavialle S., Cobret L., Duquesnoy P.et al. . (2017) Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation. PLoS ONE 12, e0175336 10.1371/journal.pone.0175336 PubMed DOI PMC

Tarique A.A., Logan J., Thomas E., Holt P.G., Sly P.D. and Fantino E. (2015) Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. Am. J. Respir. Cell Mol. Biol. 53, 676–688 10.1165/rcmb.2015-0012OC PubMed DOI

Cao X., Chen J., Li B., Dang J., Zhang W., Zhong X.et al. . (2022) Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapy. Sci. Adv. 8, eabl9171 10.1126/sciadv.abl9171 PubMed DOI PMC

Yamane K. and Leung K.P. (2016) Rabbit M1 and M2 macrophages can be induced by human recombinant GM-CSF and M-CSF. FEBS Open Bio. 6, 945–953 10.1002/2211-5463.12101 PubMed DOI PMC

Qin H., Holdbrooks A.T., Liu Y., Reynolds S.L., Yanagisawa L.L. and Benveniste E.N. (2012) SOCS3 deficiency promotes M1 macrophage polarization and inflammation. J. Immunol. 189, 3439–3448 10.4049/jimmunol.1201168 PubMed DOI PMC

Thomas L., Rao Z., Gerstmeier J., Raasch M., Weinigel C., Rummler S.et al. . (2017) Selective upregulation of TNFalpha expression in classically-activated human monocyte-derived macrophages (M1) through pharmacological interference with V-ATPase. Biochem. Pharmacol. 130, 71–82 10.1016/j.bcp.2017.02.004 PubMed DOI

Gajanayaka N., Dong S.X.M., Ali H., Iqbal S., Mookerjee A., Lawton D.A.et al. . (2021) TLR-4 agonist induces IFN-gamma production selectively in proinflammatory human M1 macrophages through the PI3K-mTOR- and JNK-MAPK-activated p70S6K pathway. J. Immunol. 207, 2310–2324 10.4049/jimmunol.2001191 PubMed DOI

Farooque A., Afrin F., Adhikari J.S. and Dwarakanath B.S. (2016) Polarization of macrophages towards M1 phenotype by a combination of 2-deoxy-d-glucose and radiation: implications for tumor therapy. Immunobiology 221, 269–281 10.1016/j.imbio.2015.10.009 PubMed DOI

Kovacevic Z., Sahni S., Lok H., Davies M.J., Wink D.A. and Richardson D.R. (2017) Regulation and control of nitric oxide (NO) in macrophages: Protecting the “professional killer cell” from its own cytotoxic arsenal via MRP1 and GSTP1. Biochim. Biophys. Acta Gen. Subj. 1861, 995–999 10.1016/j.bbagen.2017.02.021 PubMed DOI

Mia S., Warnecke A., Zhang X.M., Malmstrom V. and Harris R.A. (2014) An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-beta yields a dominant immunosuppressive phenotype. Scand. J. Immunol. 79, 305–314 10.1111/sji.12162 PubMed DOI PMC

Zhang M.Z., Wang X., Wang Y., Niu A., Wang S., Zou C.et al. . (2017) IL-4/IL-13-mediated polarization of renal macrophages/dendritic cells to an M2a phenotype is essential for recovery from acute kidney injury. Kidney Int. 91, 375–386 10.1016/j.kint.2016.08.020 PubMed DOI PMC

Anders H.J. and Ryu M. (2011) Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int. 80, 915–925 10.1038/ki.2011.217 PubMed DOI

Yue Y., Yang X., Feng K., Wang L., Hou J., Mei B.et al. . (2017) M2b macrophages reduce early reperfusion injury after myocardial ischemia in mice: a predominant role of inhibiting apoptosis via A20. Int. J. Cardiol. 245, 228–235 10.1016/j.ijcard.2017.07.085 PubMed DOI

Asai A., Nakamura K., Kobayashi M., Herndon D.N. and Suzuki F. (2012) CCL1 released from M2b macrophages is essentially required for the maintenance of their properties. J. Leukoc. Biol. 92, 859–867 10.1189/jlb.0212107 PubMed DOI

Zhang B., Bailey W.M., Braun K.J. and Gensel J.C. (2015) Age decreases macrophage IL-10 expression: implications for functional recovery and tissue repair in spinal cord injury. Exp. Neurol. 273, 83–91 10.1016/j.expneurol.2015.08.001 PubMed DOI PMC

Huang X., Li Y., Fu M. and Xin H.B. (2018) Polarizing macrophages in vitro. Methods Mol. Biol. 1784, 119–126 10.1007/978-1-4939-7837-3_12 PubMed DOI PMC

Olmes G., Buttner-Herold M., Ferrazzi F., Distel L., Amann K. and Daniel C. (2016) CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis. Arthritis Res. Ther. 18, 90 10.1186/s13075-016-0989-y PubMed DOI PMC

Schaer D.J., Schaer C.A., Buehler P.W., Boykins R.A., Schoedon G., Alayash A.I.et al. . (2006) CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. Blood 107, 373–380 10.1182/blood-2005-03-1014 PubMed DOI

Ferrante C.J., Pinhal-Enfield G., Elson G., Cronstein B.N., Hasko G., Outram S.et al. . (2013) The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Ralpha) signaling. Inflammation 36, 921–931 10.1007/s10753-013-9621-3 PubMed DOI PMC

Nikovics K., Morin H., Riccobono D., Bendahmane A. and Favier A.L. (2020) Hybridization-chain-reaction is a relevant method for in situ detection of M2d-like macrophages in a mini-pig model. FASEB J. 34, 15675–15686 10.1096/fj.202001496R PubMed DOI

Cao W., Peters J.H., Nieman D., Sharma M., Watson T. and Yu J. (2015) Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro. Br. J. Cancer 113, 738–746 10.1038/bjc.2015.292 PubMed DOI PMC

de Leon U.A., Vazquez-Jimenez A., Matadamas-Guzman M. and Resendis-Antonio O. (2022) Boolean modeling reveals that cyclic attractors in macrophage polarization serve as reservoirs of states to balance external perturbations from the tumor microenvironment. Front. Immunol. 13, 1012730 10.3389/fimmu.2022.1012730 PubMed DOI PMC

Liu Y.C., Zou X.B., Chai Y.F. and Yao Y.M. (2014) Macrophage polarization in inflammatory diseases. Int. J. Biol. Sci. 10, 520–529 10.7150/ijbs.8879 PubMed DOI PMC

Smith M.S., Bentz G.L., Alexander J.S. and Yurochko A.D. (2004) Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J. Virol. 78, 4444–4453 10.1128/JVI.78.9.4444-4453.2004 PubMed DOI PMC

Huang Z., Luo Q., Guo Y., Chen J., Xiong G., Peng Y.et al. . (2015) Mycobacterium tuberculosis-induced polarization of human macrophage orchestrates the formation and development of tuberculous granulomas in vitro. PLoS ONE 10, e0129744 10.1371/journal.pone.0129744 PubMed DOI PMC

Matic S., Popovic S., Djurdjevic P., Todorovic D., Djordjevic N., Mijailovic Z.et al. . (2020) SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets. PLoS ONE 15, e0241097 10.1371/journal.pone.0241097 PubMed DOI PMC

Sang Y., Miller L.C. and Blecha F. (2015) Macrophage polarization in virus-host interactions. J. Clin. Cell. Immunol. 6, 311. PubMed PMC

Yu S., Ge H., Li S. and Qiu H.J. (2022) Modulation of macrophage polarization by viruses: turning off/on host antiviral responses. Front. Microbiol. 13, 839585 10.3389/fmicb.2022.839585 PubMed DOI PMC

Cassol E., Cassetta L., Alfano M. and Poli G. (2010) Macrophage polarization and HIV-1 infection. J. Leukoc. Biol. 87, 599–608 10.1189/jlb.1009673 PubMed DOI

Adams O., Besken K., Oberdorfer C., MacKenzie C.R., Russing D. and Daubener W. (2004) Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase. Microbes Infect. 6, 806–812 10.1016/j.micinf.2004.04.007 PubMed DOI

Lane B.R., Markovitz D.M., Woodford N.L., Rochford R., Strieter R.M. and Coffey M.J. (1999) TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J. Immunol. 163, 3653–3661 10.4049/jimmunol.163.7.3653 PubMed DOI

Biermer M., Puro R. and Schneider R.J. (2003) Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. J. Virol. 77, 4033–4042 10.1128/JVI.77.7.4033-4042.2003 PubMed DOI PMC

Mattiola I., Pesant M., Tentorio P.F., Molgora M., Marcenaro E., Lugli E.et al. . (2015) Priming of human resting NK cells by autologous M1 macrophages via the engagement of IL-1beta, IFN-beta, and IL-15 pathways. J. Immunol. 195, 2818–2828 10.4049/jimmunol.1500325 PubMed DOI

Lee D.H. and Ghiasi H. (2017) Roles of M1 and M2 Macrophages in Herpes Simplex Virus 1 Infectivity. J. Virol. 91, e00578–17 10.1128/JVI.00578-17 PubMed DOI PMC

Banete A., Barilo J., Whittaker R. and Basta S. (2021) The activated macrophage - a tough fortress for virus invasion: how viruses strike back. Front. Microbiol. 12, 803427 10.3389/fmicb.2021.803427 PubMed DOI PMC

Slobedman B., Barry P.A., Spencer J.V., Avdic S. and Abendroth A. (2009) Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J. Virol. 83, 9618–9629 10.1128/JVI.01098-09 PubMed DOI PMC

Kwon Y.C., Meyer K., Peng G., Chatterjee S., Hoft D.F. and Ray R. (2019) Hepatitis C Virus E2 envelope glycoprotein induces an immunoregulatory phenotype in macrophages. Hepatology 69, 1873–1884 10.1002/hep.29843 PubMed DOI PMC

Murray P.J. and Wynn T.A. (2011) Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723–737 10.1038/nri3073 PubMed DOI PMC

Bility M.T., Cheng L., Zhang Z., Luan Y., Li F., Chi L.et al. . (2014) Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages. PLoS Pathog. 10, e1004032 10.1371/journal.ppat.1004032 PubMed DOI PMC

Orecchioni M., Ghosheh Y., Pramod A.B. and Ley K. (2019) Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front. Immunol. 10, 1084 10.3389/fimmu.2019.01084 PubMed DOI PMC

Rai R.K., Vishvakarma N.K., Mohapatra T.M. and Singh S.M. (2012) Augmented macrophage differentiation and polarization of tumor-associated macrophages towards M1 subtype in listeria-administered tumor-bearing host. J. Immunother. 35, 544–554 10.1097/CJI.0b013e3182661afa PubMed DOI

Shaughnessy L.M. and Swanson J.A. (2007) The role of the activated macrophage in clearing Listeria monocytogenes infection. Front. Biosci. 12, 2683–2692 10.2741/2364 PubMed DOI PMC

Luo F., Sun X., Qu Z. and Zhang X. (2016) Salmonella typhimurium-induced M1 macrophage polarization is dependent on the bacterial O antigen. World J. Microbiol. Biotechnol. 32, 22 10.1007/s11274-015-1978-z PubMed DOI

Saliba A.E., Li L., Westermann A.J., Appenzeller S., Stapels D.A., Schulte L.N.et al. . (2016) Single-cell RNA-seq ties macrophage polarization to growth rate of intracellular Salmonella. Nat. Microbiol. 2, 16206 10.1038/nmicrobiol.2016.206 PubMed DOI

Benoit M., Desnues B. and Mege J.L. (2008) Macrophage polarization in bacterial infections. J. Immunol. 181, 3733–3739 10.4049/jimmunol.181.6.3733 PubMed DOI

Wroblewski L.E., Peek R.M. Jr and Wilson K.T. (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin. Microbiol. Rev. 23, 713–739 10.1128/CMR.00011-10 PubMed DOI PMC

Park Y.H. and Kim N. (2015) Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J. Cancer Prev. 20, 25–40 10.15430/JCP.2015.20.1.25 PubMed DOI PMC

Pathak S.K., Basu S., Basu K.K., Banerjee A., Pathak S., Bhattacharyya A.et al. . (2007) Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat. Immunol. 8, 610–618 10.1038/ni1468 PubMed DOI

Vazquez-Torres A., Xu Y., Jones-Carson J., Holden D.W., Lucia S.M., Dinauer M.C.et al. . (2000) Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287, 1655–1658 10.1126/science.287.5458.1655 PubMed DOI

Fang J., Ou Q., Wu B., Li S., Wu M., Qiu J.et al. . (2022) TcpC inhibits M1 but promotes M2 macrophage polarization via regulation of the MAPK/NF-kappaB and Akt/STAT6 pathways in urinary tract infection. Cells 11, 2674 10.3390/cells11172674 PubMed DOI PMC

Benoit M., Barbarat B., Bernard A., Olive D. and Mege J.L. (2008) Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages. Eur. J. Immunol. 38, 1065–1070 10.1002/eji.200738067 PubMed DOI

Jang J.C. and Nair M.G. (2013) Alternatively activated macrophages revisited: new insights into the regulation of immunity, inflammation and metabolic function following parasite infection. Curr. Immunol. Rev. 9, 147–156 10.2174/1573395509666131210232548 PubMed DOI PMC

Faz-Lopez B., Morales-Montor J. and Terrazas L.I. (2016) Role of macrophages in the repair process during the tissue migrating and resident helminth infections. Biomed. Res. Int. 2016, 8634603 10.1155/2016/8634603 PubMed DOI PMC

Franca-Costa J., Van Weyenbergh J., Boaventura V.S., Luz N.F., Malta-Santos H., Oliveira M.C.et al. . (2015) Arginase I, polyamine, and prostaglandin E2 pathways suppress the inflammatory response and contribute to diffuse cutaneous leishmaniasis. J. Infect. Dis. 211, 426–435 10.1093/infdis/jiu455 PubMed DOI

Farrow A.L., Rana T., Mittal M.K., Misra S. and Chaudhuri G. (2011) Leishmania-induced repression of selected non-coding RNA genes containing B-box element at their promoters in alternatively polarized M2 macrophages. Mol. Cell. Biochem. 350, 47–57 10.1007/s11010-010-0681-5 PubMed DOI

McGettrick A.F., Corcoran S.E., Barry P.J., McFarland J., Cres C., Curtis A.M.et al. . (2016) Trypanosoma brucei metabolite indolepyruvate decreases HIF-1alpha and glycolysis in macrophages as a mechanism of innate immune evasion. Proc. Natl. Acad. Sci. U.S.A. 113, E7778–E7787 10.1073/pnas.1608221113 PubMed DOI PMC

Diskin C., Corcoran S.E., Tyrrell V.J., McGettrick A.F., Zaslona Z., O'Donnell V.B.et al. . (2021) The Trypanosome-derived metabolite indole-3-pyruvate inhibits prostaglandin production in macrophages by targeting COX2. J. Immunol. 207, 2551–2560 10.4049/jimmunol.2100402 PubMed DOI

Gause W.C., Wynn T.A. and Allen J.E. (2013) Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat. Rev. Immunol. 13, 607–614 10.1038/nri3476 PubMed DOI PMC

Maizels R.M. and McSorley H.J. (2016) Regulation of the host immune system by helminth parasites. J. Allergy Clin. Immunol. 138, 666–675 10.1016/j.jaci.2016.07.007 PubMed DOI PMC

Roszer T. (2015) Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediators Inflamm. 2015, 816460 10.1155/2015/816460 PubMed DOI PMC

Maizels R.M., Smits H.H. and McSorley H.J. (2018) Modulation of host immunity by helminths: the expanding repertoire of parasite effector molecules. Immunity 49, 801–818 10.1016/j.immuni.2018.10.016 PubMed DOI PMC

van der Werf N., Redpath S.A., Azuma M., Yagita H. and Taylor M.D. (2013) Th2 cell-intrinsic hypo-responsiveness determines susceptibility to helminth infection. PLoS Pathog. 9, e1003215 10.1371/journal.ppat.1003215 PubMed DOI PMC

White R.R. and Artavanis-Tsakonas K. (2012) How helminths use excretory secretory fractions to modulate dendritic cells. Virulence 3, 668–677 10.4161/viru.22832 PubMed DOI PMC

Harris N. and Gause W.C. (2011) To B or not to B: B cells and the Th2-type immune response to helminths. Trends Immunol. 32, 80–88 10.1016/j.it.2010.11.005 PubMed DOI PMC

Hotez P.J., Brindley P.J., Bethony J.M., King C.H., Pearce E.J. and Jacobson J. (2008) Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 118, 1311–1321 10.1172/JCI34261 PubMed DOI PMC

Mantovani A., Marchesi F., Malesci A., Laghi L. and Allavena P. (2017) Tumour-associated macrophages as treatment targets in oncology. Nat. Rev. Clin. Oncol. 14, 399–416 10.1038/nrclinonc.2016.217 PubMed DOI PMC

Tcyganov E., Mastio J., Chen E. and Gabrilovich D.I. (2018) Plasticity of myeloid-derived suppressor cells in cancer. Curr. Opin. Immunol. 51, 76–82 10.1016/j.coi.2018.03.009 PubMed DOI PMC

Kwak T., Wang F., Deng H., Condamine T., Kumar V., Perego M.et al. . (2020) Distinct populations of immune-suppressive macrophages differentiate from monocytic myeloid-derived suppressor cells in cancer. Cell Rep. 33, 108571 10.1016/j.celrep.2020.108571 PubMed DOI PMC

Gabrilovich D.I. and Nagaraj S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162–174 10.1038/nri2506 PubMed DOI PMC

Locati M., Curtale G. and Mantovani A. (2020) Diversity, mechanisms, and significance of macrophage plasticity. Annu. Rev. Pathol. 15, 123–147 10.1146/annurev-pathmechdis-012418-012718 PubMed DOI PMC

Pan Y., Yu Y., Wang X. and Zhang T. (2020) Tumor-associated macrophages in tumor immunity. Front. Immunol. 11, 583084 10.3389/fimmu.2020.583084 PubMed DOI PMC

Mantovani A., Allavena P., Marchesi F. and Garlanda C. (2022) Macrophages as tools and targets in cancer therapy. Nat. Rev. Drug Discov. 21, 799–820 10.1038/s41573-022-00520-5 PubMed DOI PMC

Zhou J., Tang Z., Gao S., Li C., Feng Y. and Zhou X. (2020) Tumor-associated macrophages: recent insights and therapies. Front. Oncol. 10, 188 10.3389/fonc.2020.00188 PubMed DOI PMC

Ostuni R., Kratochvill F., Murray P.J. and Natoli G. (2015) Macrophages and cancer: from mechanisms to therapeutic implications. Trends Immunol. 36, 229–239 10.1016/j.it.2015.02.004 PubMed DOI

Boutilier A.J. and Elsawa S.F. (2021) Macrophage polarization states in the tumor microenvironment. Int. J. Mol. Sci. 22, 6995 10.3390/ijms22136995 PubMed DOI PMC

Lin Y., Xu J. and Lan H. (2019) Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J. Hematol. Oncol. 12, 76 10.1186/s13045-019-0760-3 PubMed DOI PMC

Kolesnikoff N., Chen C.H. and Samuel M.S. (2022) Interrelationships between the extracellular matrix and the immune microenvironment that govern epithelial tumour progression. Clin. Sci. (Lond.) 136, 361–377 10.1042/CS20210679 PubMed DOI PMC

Podojil J.R. and Miller S.D. (2017) Potential targeting of B7-H4 for the treatment of cancer. Immunol. Rev. 276, 40–51 10.1111/imr.12530 PubMed DOI PMC

Ocana-Guzman R., Torre-Bouscoulet L. and Sada-Ovalle I. (2016) TIM-3 regulates distinct functions in macrophages. Front. Immunol. 7, 229 10.3389/fimmu.2016.00229 PubMed DOI PMC

Liu J., Geng X., Hou J. and Wu G. (2021) New insights into M1/M2 macrophages: key modulators in cancer progression. Cancer Cell Int. 21, 389 10.1186/s12935-021-02089-2 PubMed DOI PMC

Laviron M. and Boissonnas A. (2019) Ontogeny of tumor-associated macrophages. Front. Immunol. 10, 1799 10.3389/fimmu.2019.01799 PubMed DOI PMC

Hourani T., Holden J.A., Li W., Lenzo J.C., Hadjigol S. and O'Brien-Simpson N.M. (2021) Tumor associated macrophages: origin, recruitment, phenotypic diversity, and targeting. Front. Oncol. 11, 788365 10.3389/fonc.2021.788365 PubMed DOI PMC

Chen Z., Wu J., Wang L., Zhao H. and He J. (2022) Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway. Med. Oncol. 39, 83 10.1007/s12032-022-01670-7 PubMed DOI

Chavez-Galan L., Olleros M.L., Vesin D. and Garcia I. (2015) Much more than M1 and M2 macrophages, there are also CD169(+) and TCR(+) macrophages. Front. Immunol. 6, 263. PubMed PMC

Li C., Xu X., Wei S., Jiang P., Xue L., Wang J.et al. . (2021) Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer. J. Immunother. Cancer 9, e001341 10.1136/jitc-2020-001341 PubMed DOI PMC

Bruni D., Angell H.K. and Galon J. (2020) The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nat. Rev. Cancer 20, 662–680 10.1038/s41568-020-0285-7 PubMed DOI

Rojas A., Araya P., Romero J., Delgado-Lopez F., Gonzalez I., Anazco C.et al. . (2018) Skewed Signaling through the Receptor for Advanced Glycation End-Products Alters the Proinflammatory Profile of Tumor-Associated Macrophages. Cancer Microenviron. 11, 97–105 10.1007/s12307-018-0214-4 PubMed DOI PMC

Wang X., Xu Y., Sun Q., Zhou X., Ma W., Wu J.et al. . (2022) New insights from the single-cell level: Tumor associated macrophages heterogeneity and personalized therapy. Biomed. Pharmacother. 153, 113343 10.1016/j.biopha.2022.113343 PubMed DOI

Poh A.R. and Ernst M. (2018) Targeting macrophages in cancer: from bench to bedside. Front. Oncol. 8, 49 10.3389/fonc.2018.00049 PubMed DOI PMC

Wang X. and Lin Y. (2008) Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol. Sin. 29, 1275–1288 10.1111/j.1745-7254.2008.00889.x PubMed DOI PMC

Mercogliano M.F., Bruni S., Mauro F., Elizalde P.V. and Schillaci R. (2021) Harnessing tumor necrosis factor alpha to achieve effective cancer immunotherapy. Cancers (Basel) 13, 564 10.3390/cancers13030564 PubMed DOI PMC

Hirano T. (2021) IL-6 in inflammation, autoimmunity and cancer. Int. Immunol. 33, 127–148 10.1093/intimm/dxaa078 PubMed DOI PMC

Radharani N.N.V., Yadav A.S., Nimma R., Kumar T.V.S., Bulbule A., Chanukuppa V.et al. . (2022) Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway. Cancer Cell Int. 22, 122 10.1186/s12935-022-02527-9 PubMed DOI PMC

Fisher D.T., Appenheimer M.M. and Evans S.S. (2014) The two faces of IL-6 in the tumor microenvironment. Semin. Immunol. 26, 38–47 10.1016/j.smim.2014.01.008 PubMed DOI PMC

Voronov E., Carmi Y. and Apte R.N. (2014) The role IL-1 in tumor-mediated angiogenesis. Front. Physiol. 5, 114 10.3389/fphys.2014.00114 PubMed DOI PMC

Apte R.N., Dotan S., Elkabets M., White M.R., Reich E., Carmi Y.et al. . (2006) The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev. 25, 387–408 10.1007/s10555-006-9004-4 PubMed DOI

Hanahan D. and Weinberg R.A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646–674 10.1016/j.cell.2011.02.013 PubMed DOI

Binnewies M., Roberts E.W., Kersten K., Chan V., Fearon D.F., Merad M.et al. . (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541–550 10.1038/s41591-018-0014-x PubMed DOI PMC

Galon J. and Bruni D. (2020) Tumor immunology and tumor evolution: intertwined histories. Immunity 52, 55–81 10.1016/j.immuni.2019.12.018 PubMed DOI

Jiang J., Mei J., Ma Y., Jiang S., Zhang J., Yi S.et al. . (2022) Tumor hijacks macrophages and microbiota through extracellular vesicles. Exploration 2, 20210144 10.1002/EXP.20210144 PubMed DOI PMC

Wu P., Wu D., Zhao L., Huang L., Chen G., Shen G.et al. . (2016) Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis. Oncotarget 7, 40451–40460 10.18632/oncotarget.9625 PubMed DOI PMC

Kumar A.T., Knops A., Swendseid B., Martinez-Outschoom U., Harshyne L., Philp N.et al. . (2019) Prognostic significance of tumor-associated macrophage content in head and neck squamous cell carcinoma: a meta-analysis. Front. Oncol. 9, 656 10.3389/fonc.2019.00656 PubMed DOI PMC

Yu M., Guan R., Hong W., Zhou Y., Lin Y., Jin H.et al. . (2019) Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysis. Cancer Manag. Res. 11, 4041–4058 10.2147/CMAR.S196951 PubMed DOI PMC

Larionova I., Cherdyntseva N., Liu T., Patysheva M., Rakina M. and Kzhyshkowska J. (2019) Interaction of tumor-associated macrophages and cancer chemotherapy. Oncoimmunology 8, 1596004 10.1080/2162402X.2019.1596004 PubMed DOI PMC

Genard G., Lucas S. and Michiels C. (2017) Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo- and immunotherapies. Front. Immunol. 8, 828 10.3389/fimmu.2017.00828 PubMed DOI PMC

Beach C., MacLean D., Majorova D., Arnold J.N. and Olcina M.M. (2022) The effects of radiation therapy on the macrophage response in cancer. Front. Oncol. 12, 1020606 10.3389/fonc.2022.1020606 PubMed DOI PMC

Duan Z. and Luo Y. (2021) Targeting macrophages in cancer immunotherapy. Signal Transduct. Target Ther. 6, 127 10.1038/s41392-021-00506-6 PubMed DOI PMC

Haberman R.H., Herati R., Simon D., Samanovic M., Blank R.B., Tuen M.et al. . (2021) Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease. Ann. Rheum. Dis. 801339–1344annrheumdis-2021-220597 10.1136/annrheumdis-2021-220597 PubMed DOI PMC

Kumar A., Taghi Khani A., Sanchez Ortiz A. and Swaminathan S. (2022) GM-CSF: a double-edged sword in cancer immunotherapy. Front. Immunol. 13, 901277 10.3389/fimmu.2022.901277 PubMed DOI PMC

Navegantes K.C., de Souza Gomes R., Pereira P.A.T., Czaikoski P.G., Azevedo C.H.M. and Monteiro M.C. (2017) Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity. J. Transl. Med. 15, 36 10.1186/s12967-017-1141-8 PubMed DOI PMC

Ma W.T., Gao F., Gu K. and Chen D.K. (2019) The role of monocytes and macrophages in autoimmune diseases: a comprehensive review. Front. Immunol. 10, 1140 10.3389/fimmu.2019.01140 PubMed DOI PMC

Funes S.C., Rios M., Escobar-Vera J. and Kalergis A.M. (2018) Implications of macrophage polarization in autoimmunity. Immunology 154, 186–195 10.1111/imm.12910 PubMed DOI PMC

Menzies F.M., Henriquez F.L., Alexander J. and Roberts C.W. (2011) Selective inhibition and augmentation of alternative macrophage activation by progesterone. Immunology 134, 281–291 10.1111/j.1365-2567.2011.03488.x PubMed DOI PMC

Routley C.E. and Ashcroft G.S. (2009) Effect of estrogen and progesterone on macrophage activation during wound healing. Wound Repair Regen. 17, 42–50 10.1111/j.1524-475X.2008.00440.x PubMed DOI

Deane S., Selmi C., Teuber S.S. and Gershwin M.E. (2010) Macrophage activation syndrome in autoimmune disease. Int. Arch. Allergy Immunol. 153, 109–120 10.1159/000312628 PubMed DOI

Kang Y.E., Kim J.M., Joung K.H., Lee J.H., You B.R., Choi M.J.et al. . (2016) The roles of adipokines, proinflammatory cytokines, and adipose tissue macrophages in obesity-associated insulin resistance in modest obesity and early metabolic dysfunction. PLoS ONE 11, e0154003 10.1371/journal.pone.0154003 PubMed DOI PMC

Liang W., Qi Y., Yi H., Mao C., Meng Q., Wang H.et al. . (2022) The roles of adipose tissue macrophages in human disease. Front. Immunol. 13, 908749 10.3389/fimmu.2022.908749 PubMed DOI PMC

Husseini M., Wang G.-S., Patrick C., Crookshank J.A., MacFarlane A.J., Noel J.A.et al. . (2015) Heme oxygenase-1 induction prevents autoimmune diabetes in association with pancreatic recruitment of M2-like macrophages, mesenchymal cells, and fibrocytes. Endocrinology 156, 3937–3949 10.1210/en.2015-1304 PubMed DOI

Cosentino C. and Regazzi R. (2021) Crosstalk between macrophages and pancreatic β-cells in islet development, homeostasis and disease. Int. J. Mol. Sci. 22, 1765 10.3390/ijms22041765 PubMed DOI PMC

Dalmas E. (2019) Innate immune priming of insulin secretion. Curr. Opin. Immunol. 56, 44–49 10.1016/j.coi.2018.10.005 PubMed DOI

Li H., Meng Y., He S., Tan X., Zhang Y., Zhang X.et al. . (2022) Macrophages, chronic inflammation, and insulin resistance. Cells 11, 3001 10.3390/cells11193001 PubMed DOI PMC

Ahamada M.M., Jia Y. and Wu X. (2021) Macrophage polarization and plasticity in systemic lupus erythematosus. Front. Immunol. 12, 734008 10.3389/fimmu.2021.734008 PubMed DOI PMC

Ma C., Xia Y., Yang Q. and Zhao Y. (2019) The contribution of macrophages to systemic lupus erythematosus. Clin. Immunol. 207, 1–9 10.1016/j.clim.2019.06.009 PubMed DOI

Li F., Yang Y., Zhu X., Huang L. and Xu J. (2015) Macrophage polarization modulates development of systemic lupus erythematosus. Cell. Physiol. Biochem. 37, 1279–1288 10.1159/000430251 PubMed DOI

van Dalen F.J., van Stevendaal M., Fennemann F.L., Verdoes M. and Ilina O. (2018) Molecular repolarisation of tumour-associated macrophages. Molecules 24, 9 10.3390/molecules24010009 PubMed DOI PMC

Song S., De S., Nelson V., Chopra S., LaPan M., Kampta K.et al. . (2020) Inhibition of IRF5 hyperactivation protects from lupus onset and severity. J. Clin. Invest. 130, 6700–6717 10.1172/JCI120288 PubMed DOI PMC

Krausgruber T., Blazek K., Smallie T., Alzabin S., Lockstone H., Sahgal N.et al. . (2011) IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12, 231–238 10.1038/ni.1990 PubMed DOI

Cutolo M., Campitiello R., Gotelli E. and Soldano S. (2022) The role of M1/M2 macrophage polarization in rheumatoid arthritis synovitis. Front. Immunol. 13, 867260 10.3389/fimmu.2022.867260 PubMed DOI PMC

Najm A. and McInnes I.B. (2021) IL-23 orchestrating immune cell activation in arthritis. Rheumatology (Oxford). 60, iv4–iv15 10.1093/rheumatology/keab266 PubMed DOI PMC

Braun T. and Zwerina J. (2011) Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Res. Ther. 13, 235 10.1186/ar3380 PubMed DOI PMC

Scheinman R. (2013) NF-kappaB and rheumatoid arthritis: will understanding genetic risk lead to a therapeutic reward? For. Immunopathol. Dis. Therap. 4, 93–110 PubMed PMC

Jeganathan S., Fiorino C., Naik U., Sun H.S. and Harrison R.E. (2014) Modulation of osteoclastogenesis with macrophage M1- and M2-inducing stimuli. PLoS ONE 9, e104498 10.1371/journal.pone.0104498 PubMed DOI PMC

Fukui S., Iwamoto N., Takatani A., Igawa T., Shimizu T., Umeda M.et al. . (2017) M1 and M2 monocytes in rheumatoid arthritis: a contribution of imbalance of M1/M2 monocytes to osteoclastogenesis. Front. Immunol. 8, 1958 10.3389/fimmu.2017.01958 PubMed DOI PMC

Xu Y., Zhang Z., He J. and Chen Z. (2022) Immune effects of macrophages in rheumatoid arthritis: a bibliometric analysis from 2000 to 2021. Front. Immunol. 13, 903771 10.3389/fimmu.2022.903771 PubMed DOI PMC

Toledo D.M. and Pioli P.A. (2019) Macrophages in systemic sclerosis: novel insights and therapeutic implications. Curr. Rheumatol. Rep. 21, 31 10.1007/s11926-019-0831-z PubMed DOI PMC

Al-Adwi Y., Westra J., van Goor H., Burgess J.K., Denton C.P. and Mulder D.J. (2023) Macrophages as determinants and regulators of fibrosis in systemic sclerosis. Rheumatology (Oxford). 62, 535–545 10.1093/rheumatology/keac410 PubMed DOI PMC

Vallee A. and Lecarpentier Y. (2019) TGF-beta in fibrosis by acting as a conductor for contractile properties of myofibroblasts. Cell Biosci. 9, 98 10.1186/s13578-019-0362-3 PubMed DOI PMC

Zhou D. and McNamara N.A. (2014) Macrophages: important players in primary Sjogren's syndrome? Expert Rev. Clin. Immunol. 10, 513–520 10.1586/1744666X.2014.900441 PubMed DOI

Sequi-Sabater J.M. and Beretta L. (2022) Defining the role of monocytes in Sjogren's syndrome. Int. J. Mol. Sci. 23, 10.3390/ijms232112765 PubMed DOI PMC

Susser L.I. and Rayner K.J. (2022) Through the layers: how macrophages drive atherosclerosis across the vessel wall. J. Clin. Invest. 132, e157011 10.1172/JCI157011 PubMed DOI PMC

Eshghjoo S., Kim D.M., Jayaraman A., Sun Y. and Alaniz R.C. (2022) Macrophage polarization in atherosclerosis. Genes (Basel) 13, 756 10.3390/genes13050756 PubMed DOI PMC

Sun X., Li Y., Deng Q., Hu Y., Dong J., Wang W.et al. . (2022) Macrophage polarization, metabolic reprogramming, and inflammatory effects in ischemic heart disease. Front. Immunol. 13, 934040 10.3389/fimmu.2022.934040 PubMed DOI PMC

Shaikh S., Brittenden J., Lahiri R., Brown P.A., Thies F. and Wilson H.M. (2012) Macrophage subtypes in symptomatic carotid artery and femoral artery plaques. Eur. J. Vasc. Endovasc. Surg. 44, 491–497 10.1016/j.ejvs.2012.08.005 PubMed DOI

Cho K.Y., Miyoshi H., Kuroda S., Yasuda H., Kamiyama K., Nakagawara J.et al. . (2013) The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery. J. Stroke Cerebrovasc. Dis. 22, 910–918 10.1016/j.jstrokecerebrovasdis.2012.11.020 PubMed DOI

Stoger J.L., Gijbels M.J., van der Velden S., Manca M., van der Loos C.M., Biessen E.A.et al. . (2012) Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 225, 461–468 10.1016/j.atherosclerosis.2012.09.013 PubMed DOI

Farias-Itao D.S., Pasqualucci C.A., de Andrade R.A., da Silva L.F.F., Yahagi-Estevam M., Lage S.H.G.et al. . (2022) Macrophage polarization in the perivascular fat was associated with coronary atherosclerosis. J. Am. Heart Assoc. 11, e023274 10.1161/JAHA.121.023274 PubMed DOI PMC

Bengtsson E., Hultman K., Edsfeldt A., Persson A., Nitulescu M., Nilsson J.et al. . (2020) CD163+ macrophages are associated with a vulnerable plaque phenotype in human carotid plaques. Sci. Rep. 10, 14362 10.1038/s41598-020-71110-x PubMed DOI PMC

Landis R.C., Philippidis P., Domin J., Boyle J.J. and Haskard D.O. (2013) Haptoglobin genotype-dependent anti-inflammatory signaling in CD163(+) macrophages. Int J Inflam 2013, 980327 10.1155/2013/980327 PubMed DOI PMC

Boyle J.J., Harrington H.A., Piper E., Elderfield K., Stark J., Landis R.C.et al. . (2009) Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am. J. Pathol. 174, 1097–1108 10.2353/ajpath.2009.080431 PubMed DOI PMC

da Rocha R.F., De Bastiani M.A. and Klamt F. (2014) Bioinformatics approach to evaluate differential gene expression of M1/M2 macrophage phenotypes and antioxidant genes in atherosclerosis. Cell Biochem. Biophys. 70, 831–839 10.1007/s12013-014-9987-3 PubMed DOI

Hirata Y., Tabata M., Kurobe H., Motoki T., Akaike M., Nishio C.et al. . (2011) Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J. Am. Coll. Cardiol. 58, 248–255 10.1016/j.jacc.2011.01.048 PubMed DOI

Yang M., Kumar R.K., Hansbro P.M. and Foster P.S. (2012) Emerging roles of pulmonary macrophages in driving the development of severe asthma. J. Leukoc. Biol. 91, 557–569 10.1189/jlb.0711357 PubMed DOI

Cai Y., Sugimoto C., Arainga M., Alvarez X., Didier E.S. and Kuroda M.J. (2014) In vivo characterization of alveolar and interstitial lung macrophages in rhesus macaques: implications for understanding lung disease in humans. J. Immunol. 192, 2821–2829 10.4049/jimmunol.1302269 PubMed DOI PMC

Grunberg K. and Sterk P.J. (1999) Rhinovirus infections: induction and modulation of airways inflammation in asthma. Clin. Exp. Allergy 29, 65–73 10.1046/j.1365-2222.1999.00011.x PubMed DOI PMC

Loke P., Nair M.G., Parkinson J., Guiliano D., Blaxter M. and Allen J.E. (2002) IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol. 3, 7 10.1186/1471-2172-3-7 PubMed DOI PMC

Stein M., Keshav S., Harris N. and Gordon S. (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287–292 10.1084/jem.176.1.287 PubMed DOI PMC

Prasse A., Germann M., Pechkovsky D.V., Markert A., Verres T., Stahl M.et al. . (2007) IL-10-producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients. J. Allergy Clin. Immunol. 119, 464–471 10.1016/j.jaci.2006.09.030 PubMed DOI

Girodet P.O., Nguyen D., Mancini J.D., Hundal M., Zhou X., Israel E.et al. . (2016) Alternative macrophage activation is increased in asthma. Am. J. Respir. Cell Mol. Biol. 55, 467–475 10.1165/rcmb.2015-0295OC PubMed DOI PMC

Kim E.Y., Battaile J.T., Patel A.C., You Y., Agapov E., Grayson M.H.et al. . (2008) Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 14, 633–640 10.1038/nm1770 PubMed DOI PMC

Melgert B.N., ten Hacken N.H., Rutgers B., Timens W., Postma D.S. and Hylkema M.N. (2011) More alternative activation of macrophages in lungs of asthmatic patients. J. Allergy Clin. Immunol. 127, 831–833 10.1016/j.jaci.2010.10.045 PubMed DOI

Lee J.S., Koh J.Y., Yi K., Kim Y.I., Park S.J., Kim E.H.et al. . (2021) Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets. Nat. Commun. 12, 4567 10.1038/s41467-021-24807-0 PubMed DOI PMC

Robbe P., Draijer C., Borg T.R., Luinge M., Timens W., Wouters I.M.et al. . (2015) Distinct macrophage phenotypes in allergic and nonallergic lung inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 308, L358–L367 10.1152/ajplung.00341.2014 PubMed DOI

Jiang Z. and Zhu L. (2016) Update on the role of alternatively activated macrophages in asthma. J. Asthma Allergy 9, 101–107 10.2147/JAA.S104508 PubMed DOI PMC

Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A. and Locati M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677–686 10.1016/j.it.2004.09.015 PubMed DOI

Saradna A., Do D.C., Kumar S., Fu Q.L. and Gao P. (2018) Macrophage polarization and allergic asthma. Transl. Res. 191, 1–14 10.1016/j.trsl.2017.09.002 PubMed DOI PMC

Siddiqui S., Secor E.R. Jr and Silbart L.K. (2013) Broncho-alveolar macrophages express chemokines associated with leukocyte migration in a mouse model of asthma. Cell. Immunol. 281, 159–169 10.1016/j.cellimm.2013.03.001 PubMed DOI

Staples K.J., Hinks T.S., Ward J.A., Gunn V., Smith C. and Djukanovic R. (2012) Phenotypic characterization of lung macrophages in asthmatic patients: overexpression of CCL17. J. Allergy Clin. Immunol. 130, 1404e1407–1412e1407 10.1016/j.jaci.2012.07.023 PubMed DOI PMC

Kuo C.H., Tsai M.L., Li C.H., Hsiao H.P., Chao M.C., Lee M.S.et al. . (2021) Altered Pattern of Macrophage Polarization as a Biomarker for Severity of Childhood Asthma. J. Inflamm. Res. 14, 6011–6023 10.2147/JIR.S319754 PubMed DOI PMC

Curnova L., Mezerova K., Svachova V., Fialova M., Novotny M., Cecrdlova E.et al. . (2020) Up-regulation of CD163 expression in subpopulations of blood monocytes after kidney allograft transplantation. Physiol. Res. 69, 885–896 10.33549/physiolres.934531 PubMed DOI PMC

Sekerkova A., Krepsova E., Brabcova E., Slatinska J., Viklicky O., Lanska V.et al. . (2014) CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation. BMC Immunol. 15, 4 10.1186/1471-2172-15-4 PubMed DOI PMC

Higham A., Scott T., Li J., Gaskell R., Dikwa A.B., Shah R.et al. . (2020) Effects of corticosteroids on COPD lung macrophage phenotype and function. Clin. Sci. (Lond.) 134, 751–763 10.1042/CS20191202 PubMed DOI

Ordikhani F., Pothula V., Sanchez-Tarjuelo R., Jordan S. and Ochando J. (2020) Macrophages in organ transplantation. Front. Immunol. 11, 582939 10.3389/fimmu.2020.582939 PubMed DOI PMC

Michaels P.J., Kobashigawa J., Laks H., Azarbal A., Espejo M.L., Chen L.et al. . (2001) Differential expression of RANTES chemokine, TGF-beta, and leukocyte phenotype in acute cellular rejection and quilty B lesions. J. Heart Lung Transplant. 20, 407–416 10.1016/S1053-2498(00)00318-1 PubMed DOI

Bergler T., Jung B., Bourier F., Kuhne L., Banas M.C., Rummele P.et al. . (2016) Infiltration of macrophages correlates with severity of allograft rejection and outcome in human kidney transplantation. PLoS ONE 11, e0156900 10.1371/journal.pone.0156900 PubMed DOI PMC

Chu Z., Sun C., Sun L., Feng C., Yang F., Xu Y.et al. . (2020) Primed macrophages directly and specifically reject allografts. Cell. Mol. Immunol. 17, 237–246 10.1038/s41423-019-0226-0 PubMed DOI PMC

Jose M.D., Ikezumi Y., van Rooijen N., Atkins R.C. and Chadban S.J. (2003) Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 76, 1015–1022 10.1097/01.TP.0000083507.67995.13 PubMed DOI

Yu S. and Lu J. (2022) Macrophages in transplant rejection. Transpl. Immunol. 71, 101536 10.1016/j.trim.2022.101536 PubMed DOI

Hancock W.W., Thomson N.M. and Atkins R.C. (1983) Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation 35, 458–463 10.1097/00007890-198305000-00013 PubMed DOI

Kloc M. and Ghobrial R.M. (2014) Chronic allograft rejection: a significant hurdle to transplant success. Burns Trauma. 2, 3–10 10.4103/2321-3868.121646 PubMed DOI PMC

Thaunat O., Field A.C., Dai J., Louedec L., Patey N., Bloch M.F.et al. . (2005) Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response. Proc. Natl. Acad. Sci. U.S.A. 102, 14723–14728 10.1073/pnas.0507223102 PubMed DOI PMC

Kirk A.D., Hale D.A., Mannon R.B., Kleiner D.E., Hoffmann S.C., Kampen R.L.et al. . (2003) Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 76, 120–129 10.1097/01.TP.0000071362.99021.D9 PubMed DOI

Ochando J., Fayad Z.A., Madsen J.C., Netea M.G. and Mulder W.J.M. (2020) Trained immunity in organ transplantation. Am. J. Transplant. 20, 10–18 10.1111/ajt.15620 PubMed DOI PMC

Dai H., Friday A.J., Abou-Daya K.I., Williams A.L., Mortin-Toth S., Nicotra M.L.et al. . (2017) Donor SIRPalpha polymorphism modulates the innate immune response to allogeneic grafts. Sci Immunol. 2, 10.1126/sciimmunol.aam6202 PubMed DOI PMC

Zhang H., Li Z. and Li W. (2021) M2 macrophages serve as critical executor of innate immunity in chronic allograft rejection. Front. Immunol. 12, 648539 10.3389/fimmu.2021.648539 PubMed DOI PMC

Spater T., Menger M.M., Nickels R.M., Menger M.D. and Laschke M.W. (2020) Macrophages promote network formation and maturation of transplanted adipose tissue-derived microvascular fragments. J. Tissue Eng. 11, 2041731420911816 10.1177/2041731420911816 PubMed DOI PMC

Braza M.S., Conde P., Garcia M., Cortegano I., Brahmachary M., Pothula V.et al. . (2018) Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance. Am. J. Transplant. 18, 1247–1255 10.1111/ajt.14645 PubMed DOI PMC

Conde P., Rodriguez M., van der Touw W., Jimenez A., Burns M., Miller J.et al. . (2015) DC-SIGN(+) macrophages control the induction of transplantation tolerance. Immunity 42, 1143–1158 10.1016/j.immuni.2015.05.009 PubMed DOI PMC

Zhang W., Cao D., Wang M., Wu Y., Gong J., Li J.et al. . (2021) XBP1s repression regulates Kupffer cell polarization leading to immune suppressive effects protecting liver allograft in rats. Int. Immunopharmacol. 91, 107294 10.1016/j.intimp.2020.107294 PubMed DOI

Ivashkiv L.B. (2013) Epigenetic regulation of macrophage polarization and function. Trends Immunol. 34, 216–223 10.1016/j.it.2012.11.001 PubMed DOI PMC

Lawrence T. and Natoli G. (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11, 750–761 10.1038/nri3088 PubMed DOI

Zhao Y., Chen S., Lan P., Wu C., Dou Y., Xiao X.et al. . (2018) Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model. Am. J. Transplant. 18, 604–616 10.1111/ajt.14543 PubMed DOI PMC

Snyder M.E. and McDyer J.F. (2022) Alveolar macrophage subsets: accessories to lung alloimmune rejection. J. Heart Lung Transplant. 41, 1570–1571 10.1016/j.healun.2022.08.008 PubMed DOI

Moshkelgosha S., Duong A., Wilson G., Andrews T., Berra G., Renaud-Picard B.et al. . (2022) Interferon-stimulated and metallothionein-expressing macrophages are associated with acute and chronic allograft dysfunction after lung transplantation. J. Heart Lung Transplant. 41, 1556–1569 10.1016/j.healun.2022.05.005 PubMed DOI

Shen H. and Goldstein D.R. (2009) IL-6 and TNF-alpha synergistically inhibit allograft acceptance. J. Am. Soc. Nephrol. 20, 1032–1040 10.1681/ASN.2008070778 PubMed DOI PMC

Peng X., Yong Z., Xiaoyan W., Yuanshan C., Guangzhu W. and Xuehuan L. (2021) Mechanism of graft damage caused by NTPDase1-activated macrophages in acute antibody-mediated rejection. Transplant. Proc. 53, 436–442 10.1016/j.transproceed.2020.06.033 PubMed DOI

Ito M. and Fujino M. (2019) Macrophage-mediated complications after stem cell transplantation. Pathol. Int. 69, 679–687 10.1111/pin.12865 PubMed DOI

Wen Q., Kong Y., Zhao H.Y., Zhang Y.Y., Han T.T., Wang Y.et al. . (2019) G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 54, 1419–1433 10.1038/s41409-019-0449-9 PubMed DOI

Hanaki R., Toyoda H., Iwamoto S., Morimoto M., Nakato D., Ito T.et al. . (2021) Donor-derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation. Immun. Inflamm. Dis. 9, 1489–1499 10.1002/iid3.503 PubMed DOI PMC

Kawashima N., Terakura S., Nishiwaki S., Koyama D., Ozawa Y., Ito M.et al. . (2017) Increase of bone marrow macrophages and CD8(+) T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation. Bone Marrow Transplant. 52, 1164–1170 10.1038/bmt.2017.58 PubMed DOI

Broichhausen C., Riquelme P., Geissler E.K. and Hutchinson J.A. (2012) Regulatory macrophages as therapeutic targets and therapeutic agents in solid organ transplantation. Curr. Opin. Organ. Transplant 17, 332–342 10.1097/MOT.0b013e328355a979 PubMed DOI

Allison A.C. and Eugui E.M. (2005) Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation 80, S181–S190 10.1097/01.tp.0000186390.10150.66 PubMed DOI

Panzer S.E. (2022) Macrophages in transplantation: a matter of plasticity, polarization, and diversity. Transplantation 106, 257–267 10.1097/TP.0000000000003804 PubMed DOI PMC

Zhang F., Zhang J., Cao P., Sun Z. and Wang W. (2021) The characteristics of regulatory macrophages and their roles in transplantation. Int. Immunopharmacol. 91, 107322 10.1016/j.intimp.2020.107322 PubMed DOI

Tian H., Wu J. and Ma M. (2021) Implications of macrophage polarization in corneal transplantation rejection. Transpl. Immunol. 64, 101353 10.1016/j.trim.2020.101353 PubMed DOI

Fortunato M., Morali K., Passeri L. and Gregori S. (2021) Regulatory cell therapy in organ transplantation: achievements and open questions. Front. Immunol. 12, 641596 10.3389/fimmu.2021.641596 PubMed DOI PMC

Jurga A.M., Paleczna M. and Kuter K.Z. (2020) Overview of general and discriminating markers of differential microglia phenotypes. Front. Cell. Neurosci. 14, 198 10.3389/fncel.2020.00198 PubMed DOI PMC

Human Primary Monocytes as a Model for in vitro Immunotoxicity Testing: Evaluation of the Regulatory Properties of TiO2 Nanoparticles

Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature

Elevated PD-L1 and PECAM-1 as Diagnostic Biomarkers of Acute Rejection in Lung Transplantation

A comprehensive analysis of CD47 expression in various histological subtypes of soft tissue sarcoma: exploring novel opportunities for macrophage-directed treatments

ROS signaling in innate immunity via oxidative protein modifications